First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Clinical trial NCT05277051 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05277051
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2027-08-31
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.